Thread: U.S Election 2020
View Single Post
Old 04-10-2020, 08:44   #409
1andrew1
cf.mega poster
 
Join Date: Dec 2013
Posts: 15,256
1andrew1 is cast in bronze1andrew1 is cast in bronze1andrew1 is cast in bronze1andrew1 is cast in bronze
1andrew1 is cast in bronze1andrew1 is cast in bronze1andrew1 is cast in bronze1andrew1 is cast in bronze1andrew1 is cast in bronze1andrew1 is cast in bronze1andrew1 is cast in bronze1andrew1 is cast in bronze1andrew1 is cast in bronze1andrew1 is cast in bronze1andrew1 is cast in bronze1andrew1 is cast in bronze1andrew1 is cast in bronze1andrew1 is cast in bronze1andrew1 is cast in bronze1andrew1 is cast in bronze1andrew1 is cast in bronze1andrew1 is cast in bronze1andrew1 is cast in bronze
Re: U.S Election 2020
Quote:
Originally Posted by pip08456 View Post
Incorrect name? Seems like the FT has never heard of a typo. Regeron instead of Regeneron. Does make the memo look rushed though.
The FT said there were actually two errors in the memo:

b) An incorrect name was used for the drug itself. The memo of 3rd October refers to it as a polyclonal antibody therapy whilst Regeneron's antibody therapy is monoclonal. Not an expert on the differences here eg if a cocktail is used, does it become "poly"?

b) Manufacturer's name, using the name Regeron instead of Regeneron. (Regeron focuses on reverse-aging biotechnology, especially on manufacturing human polypeptide growth factors for cosmetic applications including hair care).
A potential typo or genuine confusion with the other company.
1andrew1 is offline